Tiptree (TIPT) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
28 Oct, 2026Executive summary
Q3 2026 net income attributable to common stockholders was $5.2M, or $0.14 diluted EPS; continuing operations earned $4.6M.
Nine-month net income was $408.7M, primarily reflecting the $372.8M after-tax Fortegra sale gain.
After Fortegra and Reliance were sold in May, continuing operations primarily reflected holding-company activity and investment of sale proceeds.
Financial highlights
Q3 continuing-operations pretax income was $5.1M versus an $11.4M loss YoY; nine-month pretax loss narrowed to $8.4M from $35.1M.
Q3 continuing-operations net income was $4.6M versus a $9.5M loss YoY; nine-month loss was $9.0M versus $29.7M.
Q3 total expenses fell 53.5% YoY to $6.0M; nine-month expenses declined 36.4% to $24.0M, mainly on lower compensation and professional fees.
Other income was $11.1M in Q3 and $15.9M for nine months, versus $1.2M and $2.6M YoY, primarily from interest on Treasury and corporate securities.
Nine-month discontinued-operations income was $408.680M versus $31.016M in 2025.
Outlook and guidance
USIG acquisition for $100.0M cash, subject to adjustments, regulatory approvals and customary conditions, is expected to close in Q1 2027.
Existing liquidity is expected to cover the USIG purchase price and support growth, capital expenditures and general corporate needs over the next several years.
Management cited cost control, operational streamlining, strategic insurance investments and disciplined financial management to support sustainable growth.
Latest events from Tiptree
- Book value per share surged to $24.34, fueled by major asset sales and the USIG acquisition.TIPT
Q2 2026 - Pending insurance and mortgage sales drive $14.2M Q1 net income and $912M pro-forma book value.TIPT
Q1 2026 - Shareholders will vote on director elections, equity plan changes, auditor ratification, and executive pay.TIPT
Proxy Filing - Fortegra and Reliance sales drive higher book value and strong returns, supporting long-term value.TIPT
Q4 2025 - Shareholders to vote on $1.65B Fortegra sale; board unanimously recommends approval.TIPT
Proxy Filing - Specialty insurance growth, capital discipline, and international expansion drive strong returns.TIPT
2024 Southwest IDEAS Conference - Revenue up 28% to $1.54B, net income and adjusted ROAE surged, led by insurance growth.TIPT
Q3 2024 - Record growth in specialty insurance and international expansion drive future value creation.TIPT
15th Annual Midwest IDEAS Investor Conference - Revenue and net income surged, led by record insurance growth and improved mortgage results.TIPT
Q2 2024